Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine kinase (PTK) stimulants are molecules or factors that increase the activity of PTKs, enzymes that catalyze the transfer of a phosphate group from ATP to specific tyrosine residues on protein substrates. This process is a key regulatory mechanism in cellular signal transduction, influencing cell growth, differentiation, metabolism, motility, and apoptosis. Stimulation typically involves ligand binding to receptor tyrosine kinases (RTKs), causing dimerization and autophosphorylation, or protein-protein interactions in the case of non-receptor tyrosine kinases (NRTKs). Dysregulation of PTKs can contribute to oncogenesis, while controlled stimulation may have therapeutic potential in areas like tissue regeneration.
Stimulates phosphorylation activity at specific tyrosines on target proteins, typically via ligand-induced receptor dimerization/autophosphorylation or protein-protein interactions inducing conformational changes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Tyrosine Kinase Stimulant.